カテゴリー： 世界, 医療/バイオ, LP Information

世界の骨代謝治療薬市場予測 2023年-2029年

【英語タイトル】Global Bone Metabolism Drugs Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11535）・商品コード：LP23DC11535
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の骨代謝治療薬市場」は、過去の販売実績から2022年の世界の骨代謝治療薬の総販売量を検討し、2023年から2029年の予測される骨代謝治療薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の骨代謝治療薬の市場規模を掲載し、XXX百万米ドル規模の世界の骨代謝治療薬市場の詳細な分析を提供します。本インサイトレポートは、世界の骨代謝治療薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の骨代謝治療薬市場における各社の独自のポジションをより深く理解するために、骨代謝治療薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の骨代謝治療薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。骨代謝治療薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。骨代謝治療薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。骨代謝治療薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

骨代謝治療薬の世界主要メーカーとしては、Novartis、 Organon、 Atnahs Pharma、 CTTQ、 Jiangsu Hengrui Pharmaceuticals、 Nanjing Hencer Pharmaceutical、 Chengdu Easton Biopharmaceuticals、 Shenzhen Neptunus Pharmaceutical、 Luye Pharma、 Chengdu Gowell Biopharmaceutial、 Sichuan Hairong Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の骨代謝治療薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では骨代謝治療薬市場をセグメンテーションし、種類別 (ゾレドロン酸、イバンドロン酸、アレンドロン酸、パミドロン酸、その他)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ゾレドロン酸、イバンドロン酸、アレンドロン酸、パミドロン酸、その他

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の骨代謝治療薬市場の10年間の市場状況・展望は？
・世界および地域別に見た骨代謝治療薬市場成長の要因は何か？
・骨代謝治療薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・骨代謝治療薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：骨代謝治療薬の年間販売量2018-2029、地域別現状・将来分析
・骨代謝治療薬の種類別セグメント：ゾレドロン酸、イバンドロン酸、アレンドロン酸、パミドロン酸、その他
・骨代謝治療薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・骨代謝治療薬の用途別セグメント：病院、診療所、その他
・骨代謝治療薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の骨代謝治療薬市場
・企業別のグローバル骨代謝治療薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の骨代謝治療薬の年間売上：2018-2023年の売上、市場シェア
・企業別の骨代謝治療薬販売価格
・主要企業の骨代謝治療薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

骨代謝治療薬の地域別レビュー
・地域別の骨代謝治療薬市場規模2018-2023：年間販売量、売上
・主要国別の骨代謝治療薬市場規模2018-2023：年間販売量、売上
・南北アメリカの骨代謝治療薬販売の成長
・アジア太平洋の骨代謝治療薬販売の成長
・ヨーロッパの骨代謝治療薬販売の成長
・中東・アフリカの骨代謝治療薬販売の成長

南北アメリカ市場
・南北アメリカの国別の骨代謝治療薬販売量、売上（2018-2023）
・南北アメリカの骨代謝治療薬の種類別販売量
・南北アメリカの骨代謝治療薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の骨代謝治療薬販売量、売上（2018-2023）
・アジア太平洋の骨代謝治療薬の種類別販売量
・アジア太平洋の骨代謝治療薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の骨代謝治療薬販売量、売上（2018-2023）
・ヨーロッパの骨代謝治療薬の種類別販売量
・ヨーロッパの骨代謝治療薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の骨代謝治療薬販売量、売上（2018-2023）
・中東・アフリカの骨代謝治療薬の種類別販売量
・中東・アフリカの骨代謝治療薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・骨代謝治療薬の製造コスト構造分析
・骨代謝治療薬の製造プロセス分析
・骨代謝治療薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・骨代謝治療薬の主要なグローバル販売業者
・骨代謝治療薬の主要なグローバル顧客

地域別の骨代謝治療薬市場予測レビュー
・地域別の骨代謝治療薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・骨代謝治療薬の種類別市場規模予測
・骨代謝治療薬の用途別市場規模予測

主要企業分析
Novartis、 Organon、 Atnahs Pharma、 CTTQ、 Jiangsu Hengrui Pharmaceuticals、 Nanjing Hencer Pharmaceutical、 Chengdu Easton Biopharmaceuticals、 Shenzhen Neptunus Pharmaceutical、 Luye Pharma、 Chengdu Gowell Biopharmaceutial、 Sichuan Hairong Pharmaceutical
・企業情報
・骨代謝治療薬製品
・骨代謝治療薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Bone Metabolism Drugs market size is projected to grow from US$ 226 million in 2022 to US$ 355.1 million in 2029; it is expected to grow at a CAGR of 6.7% from 2023 to 2029.
United States market for Bone Metabolism Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bone Metabolism Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bone Metabolism Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bone Metabolism Drugs players cover Novartis, Organon, Atnahs Pharma, CTTQ, Jiangsu Hengrui Pharmaceuticals, Nanjing Hencer Pharmaceutical, Chengdu Easton Biopharmaceuticals, Shenzhen Neptunus Pharmaceutical and Luye Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Bone metabolism drugs are medications that are used to treat bone-related disorders, such as osteoporosis, Paget’s disease, and bone cancer. These drugs work by either promoting bone formation or inhibiting bone resorption, which is the process of breaking down old bone tissue.
LPI (LP Information)’ newest research report, the “Bone Metabolism Drugs Industry Forecast” looks at past sales and reviews total world Bone Metabolism Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Bone Metabolism Drugs sales for 2023 through 2029. With Bone Metabolism Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Metabolism Drugs industry.
This Insight Report provides a comprehensive analysis of the global Bone Metabolism Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bone Metabolism Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone Metabolism Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Metabolism Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Metabolism Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Bone Metabolism Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Zoledronic Acid
Ibandronic Acid
Alendronic Acid
Pamidronic Acid
Other
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Novartis
Organon
Atnahs Pharma
CTTQ
Jiangsu Hengrui Pharmaceuticals
Nanjing Hencer Pharmaceutical
Chengdu Easton Biopharmaceuticals
Shenzhen Neptunus Pharmaceutical
Luye Pharma
Chengdu Gowell Biopharmaceutial
Sichuan Hairong Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bone Metabolism Drugs market?
What factors are driving Bone Metabolism Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bone Metabolism Drugs market opportunities vary by end market size?
How does Bone Metabolism Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bone Metabolism Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bone Metabolism Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bone Metabolism Drugs by Country/Region, 2018, 2022 & 2029
2.2 Bone Metabolism Drugs Segment by Type
2.2.1 Zoledronic Acid
2.2.2 Ibandronic Acid
2.2.3 Alendronic Acid
2.2.4 Pamidronic Acid
2.2.5 Other
2.3 Bone Metabolism Drugs Sales by Type
2.3.1 Global Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Bone Metabolism Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bone Metabolism Drugs Sale Price by Type (2018-2023)
2.4 Bone Metabolism Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Bone Metabolism Drugs Sales by Application
2.5.1 Global Bone Metabolism Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Bone Metabolism Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bone Metabolism Drugs Sale Price by Application (2018-2023)
3 Global Bone Metabolism Drugs by Company
3.1 Global Bone Metabolism Drugs Breakdown Data by Company
3.1.1 Global Bone Metabolism Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Bone Metabolism Drugs Sales Market Share by Company (2018-2023)
3.2 Global Bone Metabolism Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Bone Metabolism Drugs Revenue by Company (2018-2023)
3.2.2 Global Bone Metabolism Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Bone Metabolism Drugs Sale Price by Company
3.4 Key Manufacturers Bone Metabolism Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bone Metabolism Drugs Product Location Distribution
3.4.2 Players Bone Metabolism Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bone Metabolism Drugs by Geographic Region
4.1 World Historic Bone Metabolism Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Bone Metabolism Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bone Metabolism Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bone Metabolism Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Bone Metabolism Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bone Metabolism Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bone Metabolism Drugs Sales Growth
4.4 APAC Bone Metabolism Drugs Sales Growth
4.5 Europe Bone Metabolism Drugs Sales Growth
4.6 Middle East & Africa Bone Metabolism Drugs Sales Growth
5 Americas
5.1 Americas Bone Metabolism Drugs Sales by Country
5.1.1 Americas Bone Metabolism Drugs Sales by Country (2018-2023)
5.1.2 Americas Bone Metabolism Drugs Revenue by Country (2018-2023)
5.2 Americas Bone Metabolism Drugs Sales by Type
5.3 Americas Bone Metabolism Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone Metabolism Drugs Sales by Region
6.1.1 APAC Bone Metabolism Drugs Sales by Region (2018-2023)
6.1.2 APAC Bone Metabolism Drugs Revenue by Region (2018-2023)
6.2 APAC Bone Metabolism Drugs Sales by Type
6.3 APAC Bone Metabolism Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bone Metabolism Drugs by Country
7.1.1 Europe Bone Metabolism Drugs Sales by Country (2018-2023)
7.1.2 Europe Bone Metabolism Drugs Revenue by Country (2018-2023)
7.2 Europe Bone Metabolism Drugs Sales by Type
7.3 Europe Bone Metabolism Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bone Metabolism Drugs by Country
8.1.1 Middle East & Africa Bone Metabolism Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bone Metabolism Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Bone Metabolism Drugs Sales by Type
8.3 Middle East & Africa Bone Metabolism Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bone Metabolism Drugs
10.3 Manufacturing Process Analysis of Bone Metabolism Drugs
10.4 Industry Chain Structure of Bone Metabolism Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bone Metabolism Drugs Distributors
11.3 Bone Metabolism Drugs Customer
12 World Forecast Review for Bone Metabolism Drugs by Geographic Region
12.1 Global Bone Metabolism Drugs Market Size Forecast by Region
12.1.1 Global Bone Metabolism Drugs Forecast by Region (2024-2029)
12.1.2 Global Bone Metabolism Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bone Metabolism Drugs Forecast by Type
12.7 Global Bone Metabolism Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Bone Metabolism Drugs Product Portfolios and Specifications
13.1.3 Novartis Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Organon
13.2.1 Organon Company Information
13.2.2 Organon Bone Metabolism Drugs Product Portfolios and Specifications
13.2.3 Organon Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Organon Main Business Overview
13.2.5 Organon Latest Developments
13.3 Atnahs Pharma
13.3.1 Atnahs Pharma Company Information
13.3.2 Atnahs Pharma Bone Metabolism Drugs Product Portfolios and Specifications
13.3.3 Atnahs Pharma Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Atnahs Pharma Main Business Overview
13.3.5 Atnahs Pharma Latest Developments
13.4 CTTQ
13.4.1 CTTQ Company Information
13.4.2 CTTQ Bone Metabolism Drugs Product Portfolios and Specifications
13.4.3 CTTQ Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CTTQ Main Business Overview
13.4.5 CTTQ Latest Developments
13.5 Jiangsu Hengrui Pharmaceuticals
13.5.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.5.2 Jiangsu Hengrui Pharmaceuticals Bone Metabolism Drugs Product Portfolios and Specifications
13.5.3 Jiangsu Hengrui Pharmaceuticals Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.5.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.6 Nanjing Hencer Pharmaceutical
13.6.1 Nanjing Hencer Pharmaceutical Company Information
13.6.2 Nanjing Hencer Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
13.6.3 Nanjing Hencer Pharmaceutical Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nanjing Hencer Pharmaceutical Main Business Overview
13.6.5 Nanjing Hencer Pharmaceutical Latest Developments
13.7 Chengdu Easton Biopharmaceuticals
13.7.1 Chengdu Easton Biopharmaceuticals Company Information
13.7.2 Chengdu Easton Biopharmaceuticals Bone Metabolism Drugs Product Portfolios and Specifications
13.7.3 Chengdu Easton Biopharmaceuticals Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chengdu Easton Biopharmaceuticals Main Business Overview
13.7.5 Chengdu Easton Biopharmaceuticals Latest Developments
13.8 Shenzhen Neptunus Pharmaceutical
13.8.1 Shenzhen Neptunus Pharmaceutical Company Information
13.8.2 Shenzhen Neptunus Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
13.8.3 Shenzhen Neptunus Pharmaceutical Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shenzhen Neptunus Pharmaceutical Main Business Overview
13.8.5 Shenzhen Neptunus Pharmaceutical Latest Developments
13.9 Luye Pharma
13.9.1 Luye Pharma Company Information
13.9.2 Luye Pharma Bone Metabolism Drugs Product Portfolios and Specifications
13.9.3 Luye Pharma Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Luye Pharma Main Business Overview
13.9.5 Luye Pharma Latest Developments
13.10 Chengdu Gowell Biopharmaceutial
13.10.1 Chengdu Gowell Biopharmaceutial Company Information
13.10.2 Chengdu Gowell Biopharmaceutial Bone Metabolism Drugs Product Portfolios and Specifications
13.10.3 Chengdu Gowell Biopharmaceutial Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Chengdu Gowell Biopharmaceutial Main Business Overview
13.10.5 Chengdu Gowell Biopharmaceutial Latest Developments
13.11 Sichuan Hairong Pharmaceutical
13.11.1 Sichuan Hairong Pharmaceutical Company Information
13.11.2 Sichuan Hairong Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
13.11.3 Sichuan Hairong Pharmaceutical Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan Hairong Pharmaceutical Main Business Overview
13.11.5 Sichuan Hairong Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Bone Metabolism Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bone Metabolism Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Zoledronic Acid
Table 4. Major Players of Ibandronic Acid
Table 5. Major Players of Alendronic Acid
Table 6. Major Players of Pamidronic Acid
Table 7. Major Players of Other
Table 8. Global Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 9. Global Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Table 10. Global Bone Metabolism Drugs Revenue by Type (2018-2023) & ($ million)
Table 11. Global Bone Metabolism Drugs Revenue Market Share by Type (2018-2023)
Table 12. Global Bone Metabolism Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 14. Global Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Table 15. Global Bone Metabolism Drugs Revenue by Application (2018-2023)
Table 16. Global Bone Metabolism Drugs Revenue Market Share by Application (2018-2023)
Table 17. Global Bone Metabolism Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Bone Metabolism Drugs Sales by Company (2018-2023) & (K Units)
Table 19. Global Bone Metabolism Drugs Sales Market Share by Company (2018-2023)
Table 20. Global Bone Metabolism Drugs Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Bone Metabolism Drugs Revenue Market Share by Company (2018-2023)
Table 22. Global Bone Metabolism Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Bone Metabolism Drugs Producing Area Distribution and Sales Area
Table 24. Players Bone Metabolism Drugs Products Offered
Table 25. Bone Metabolism Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Bone Metabolism Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Bone Metabolism Drugs Sales Market Share Geographic Region (2018-2023)
Table 30. Global Bone Metabolism Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Bone Metabolism Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Bone Metabolism Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Bone Metabolism Drugs Sales Market Share by Country/Region (2018-2023)
Table 34. Global Bone Metabolism Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Bone Metabolism Drugs Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Bone Metabolism Drugs Sales by Country (2018-2023) & (K Units)
Table 37. Americas Bone Metabolism Drugs Sales Market Share by Country (2018-2023)
Table 38. Americas Bone Metabolism Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Bone Metabolism Drugs Revenue Market Share by Country (2018-2023)
Table 40. Americas Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 41. Americas Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 42. APAC Bone Metabolism Drugs Sales by Region (2018-2023) & (K Units)
Table 43. APAC Bone Metabolism Drugs Sales Market Share by Region (2018-2023)
Table 44. APAC Bone Metabolism Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Bone Metabolism Drugs Revenue Market Share by Region (2018-2023)
Table 46. APAC Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 47. APAC Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 48. Europe Bone Metabolism Drugs Sales by Country (2018-2023) & (K Units)
Table 49. Europe Bone Metabolism Drugs Sales Market Share by Country (2018-2023)
Table 50. Europe Bone Metabolism Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Bone Metabolism Drugs Revenue Market Share by Country (2018-2023)
Table 52. Europe Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 53. Europe Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Bone Metabolism Drugs Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Bone Metabolism Drugs Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Bone Metabolism Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Bone Metabolism Drugs Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Bone Metabolism Drugs
Table 61. Key Market Challenges & Risks of Bone Metabolism Drugs
Table 62. Key Industry Trends of Bone Metabolism Drugs
Table 63. Bone Metabolism Drugs Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Bone Metabolism Drugs Distributors List
Table 66. Bone Metabolism Drugs Customer List
Table 67. Global Bone Metabolism Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Bone Metabolism Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Bone Metabolism Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Bone Metabolism Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Bone Metabolism Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Bone Metabolism Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Bone Metabolism Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Bone Metabolism Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Bone Metabolism Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Bone Metabolism Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Bone Metabolism Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Bone Metabolism Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Bone Metabolism Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Bone Metabolism Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Novartis Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis Bone Metabolism Drugs Product Portfolios and Specifications
Table 83. Novartis Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Organon Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Organon Bone Metabolism Drugs Product Portfolios and Specifications
Table 88. Organon Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Organon Main Business
Table 90. Organon Latest Developments
Table 91. Atnahs Pharma Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Atnahs Pharma Bone Metabolism Drugs Product Portfolios and Specifications
Table 93. Atnahs Pharma Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Atnahs Pharma Main Business
Table 95. Atnahs Pharma Latest Developments
Table 96. CTTQ Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. CTTQ Bone Metabolism Drugs Product Portfolios and Specifications
Table 98. CTTQ Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. CTTQ Main Business
Table 100. CTTQ Latest Developments
Table 101. Jiangsu Hengrui Pharmaceuticals Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Jiangsu Hengrui Pharmaceuticals Bone Metabolism Drugs Product Portfolios and Specifications
Table 103. Jiangsu Hengrui Pharmaceuticals Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Jiangsu Hengrui Pharmaceuticals Main Business
Table 105. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 106. Nanjing Hencer Pharmaceutical Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Nanjing Hencer Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
Table 108. Nanjing Hencer Pharmaceutical Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Nanjing Hencer Pharmaceutical Main Business
Table 110. Nanjing Hencer Pharmaceutical Latest Developments
Table 111. Chengdu Easton Biopharmaceuticals Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Chengdu Easton Biopharmaceuticals Bone Metabolism Drugs Product Portfolios and Specifications
Table 113. Chengdu Easton Biopharmaceuticals Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Chengdu Easton Biopharmaceuticals Main Business
Table 115. Chengdu Easton Biopharmaceuticals Latest Developments
Table 116. Shenzhen Neptunus Pharmaceutical Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Shenzhen Neptunus Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
Table 118. Shenzhen Neptunus Pharmaceutical Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Shenzhen Neptunus Pharmaceutical Main Business
Table 120. Shenzhen Neptunus Pharmaceutical Latest Developments
Table 121. Luye Pharma Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Luye Pharma Bone Metabolism Drugs Product Portfolios and Specifications
Table 123. Luye Pharma Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Luye Pharma Main Business
Table 125. Luye Pharma Latest Developments
Table 126. Chengdu Gowell Biopharmaceutial Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Chengdu Gowell Biopharmaceutial Bone Metabolism Drugs Product Portfolios and Specifications
Table 128. Chengdu Gowell Biopharmaceutial Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Chengdu Gowell Biopharmaceutial Main Business
Table 130. Chengdu Gowell Biopharmaceutial Latest Developments
Table 131. Sichuan Hairong Pharmaceutical Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Sichuan Hairong Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
Table 133. Sichuan Hairong Pharmaceutical Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Sichuan Hairong Pharmaceutical Main Business
Table 135. Sichuan Hairong Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Bone Metabolism Drugs
Figure 2. Bone Metabolism Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bone Metabolism Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Bone Metabolism Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bone Metabolism Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Zoledronic Acid
Figure 10. Product Picture of Ibandronic Acid
Figure 11. Product Picture of Alendronic Acid
Figure 12. Product Picture of Pamidronic Acid
Figure 13. Product Picture of Other
Figure 14. Global Bone Metabolism Drugs Sales Market Share by Type in 2022
Figure 15. Global Bone Metabolism Drugs Revenue Market Share by Type (2018-2023)
Figure 16. Bone Metabolism Drugs Consumed in Hospital
Figure 17. Global Bone Metabolism Drugs Market: Hospital (2018-2023) & (K Units)
Figure 18. Bone Metabolism Drugs Consumed in Clinic
Figure 19. Global Bone Metabolism Drugs Market: Clinic (2018-2023) & (K Units)
Figure 20. Bone Metabolism Drugs Consumed in Other
Figure 21. Global Bone Metabolism Drugs Market: Other (2018-2023) & (K Units)
Figure 22. Global Bone Metabolism Drugs Sales Market Share by Application (2022)
Figure 23. Global Bone Metabolism Drugs Revenue Market Share by Application in 2022
Figure 24. Bone Metabolism Drugs Sales Market by Company in 2022 (K Units)
Figure 25. Global Bone Metabolism Drugs Sales Market Share by Company in 2022
Figure 26. Bone Metabolism Drugs Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Bone Metabolism Drugs Revenue Market Share by Company in 2022
Figure 28. Global Bone Metabolism Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Bone Metabolism Drugs Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Bone Metabolism Drugs Sales 2018-2023 (K Units)
Figure 31. Americas Bone Metabolism Drugs Revenue 2018-2023 ($ Millions)
Figure 32. APAC Bone Metabolism Drugs Sales 2018-2023 (K Units)
Figure 33. APAC Bone Metabolism Drugs Revenue 2018-2023 ($ Millions)
Figure 34. Europe Bone Metabolism Drugs Sales 2018-2023 (K Units)
Figure 35. Europe Bone Metabolism Drugs Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Bone Metabolism Drugs Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Bone Metabolism Drugs Revenue 2018-2023 ($ Millions)
Figure 38. Americas Bone Metabolism Drugs Sales Market Share by Country in 2022
Figure 39. Americas Bone Metabolism Drugs Revenue Market Share by Country in 2022
Figure 40. Americas Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Figure 41. Americas Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Figure 42. United States Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Bone Metabolism Drugs Sales Market Share by Region in 2022
Figure 47. APAC Bone Metabolism Drugs Revenue Market Share by Regions in 2022
Figure 48. APAC Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Figure 49. APAC Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Figure 50. China Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Bone Metabolism Drugs Sales Market Share by Country in 2022
Figure 58. Europe Bone Metabolism Drugs Revenue Market Share by Country in 2022
Figure 59. Europe Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Figure 60. Europe Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Figure 61. Germany Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Bone Metabolism Drugs Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Bone Metabolism Drugs Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Figure 70. Egypt Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Bone Metabolism Drugs in 2022
Figure 76. Manufacturing Process Analysis of Bone Metabolism Drugs
Figure 77. Industry Chain Structure of Bone Metabolism Drugs
Figure 78. Channels of Distribution
Figure 79. Global Bone Metabolism Drugs Sales Market Forecast by Region (2024-2029)
Figure 80. Global Bone Metabolism Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Bone Metabolism Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Bone Metabolism Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Bone Metabolism Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Bone Metabolism Drugs Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の骨代謝治療薬市場予測 2023年-2029年] (コード：LP23DC11535)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の骨代謝治療薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のグリコーゲン代謝異常症治療薬市場予測2023-2029：OTC、Rx医薬品
  • 世界の脂質代謝異常症治療薬市場予測2023-2029：OTC、Rx治療薬
  • 世界のかゆみ止め薬市場予測 2023年-2029年
  • 世界の経口抗アレルギー薬市場予測 2023年-2029年
  • 世界の全身性抗感染症薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆